Reproductive factors and lung cancer risk: a comprehensive systematic review and meta-analysis

被引:21
作者
Yin, Xin [1 ,2 ]
Zhu, Zhiying [3 ,4 ]
Hosgood, H. Dean [5 ]
Lan, Qing [3 ,5 ]
Seow, Wei Jie [1 ,2 ,3 ,6 ,7 ]
机构
[1] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore
[2] Natl Univ Hlth Syst, Singapore 117549, Singapore
[3] NCI, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20850 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY 10065 USA
[5] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, The Bronx, NY 10461 USA
[6] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119228, Singapore
[7] Natl Univ Hlth Syst, Singapore 119228, Singapore
关键词
Lung cancer; Meta-analysis; Reproductive factors; Never-smokers; Parity; HORMONE REPLACEMENT THERAPY; ESTROGEN-RECEPTOR-BETA; NIH-AARP DIET; POSTMENOPAUSAL WOMEN; CHINESE WOMEN; ORAL-CONTRACEPTIVES; MENSTRUAL-CYCLE; FAMILY-HISTORY; PLUS PROGESTIN; BREAST-CANCER;
D O I
10.1186/s12889-020-09530-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background A number of studies have investigated the association between reproductive factors and lung cancer risk, however findings are inconsistent. This meta-analysis aimed to evaluate the association between female reproductive factors and lung cancer risk. Methods We conducted a comprehensive systematic search to identify relevant and eligible studies published before 18th December 2019. Inter-study heterogeneity was assessed using theQtest andI(2)statistic. Based on the heterogeneity of each reproductive factor, fixed or random effects models were used to calculate the summary odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup analyses by study design, lung cancer subtypes, smoking status, and ethnicity were also performed. Results A total of 66 studies with 20 distinct reproductive factors were included in this meta-analysis. Comparing the highest and lowest categories (reference) of each reproductive factor, parity (OR = 0.83, 95% CI = 0.72-0.96), menstrual cycle length (OR = 0.79, 95% CI = 0.65-0.96), and age at first birth (OR = 0.85, 95% CI = 0.74-0.98), were significantly associated with a lower risk of overall lung cancer. On the contrary, non-natural menopause was significantly associated with higher lung cancer risk (OR = 1.52, 95% CI = 1.25-1.86). Among never-smokers, a significant negative association was found between parity and lung cancer risk. Both parity and non-natural menopause were statistically significant in case-control studies. Conclusion These results suggest that certain reproductive factors may be associated with lung cancer risk. Future studies should further validate the associations, and investigate the underlying mechanisms.
引用
收藏
页数:12
相关论文
共 125 条
  • [1] RISK OF CANCER IN WOMEN RECEIVING HORMONE REPLACEMENT THERAPY
    ADAMI, HO
    PERSSON, I
    HOOVER, R
    SCHAIRER, C
    BERGKVIST, L
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (05) : 833 - 839
  • [2] Epidemiology of lung cancer - ACCP evidence-based clinical practice guidelines (2nd edition)
    Alberg, Anthony J.
    Ford, Jean G.
    Samet, Jonathan M.
    [J]. CHEST, 2007, 132 (03) : 29S - 55S
  • [3] [Anonymous], JAMA J AM MED ASSOC
  • [4] [Anonymous], J NATL CANCER I
  • [5] Reproductive Factors, Hormone Use, and Risk for Lung Cancer in Postmenopausal Women, the Nurses' Health Study
    Baik, Christina S.
    Strauss, Gary M.
    Speizer, Frank E.
    Feskanich, Diane
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (10) : 2525 - 2533
  • [6] Differences in ovarian hormones in relation to parity and time since last birth
    Barrett, Emily S.
    Parlett, Lauren E.
    Windham, Gayle C.
    Swan, Shanna H.
    [J]. FERTILITY AND STERILITY, 2014, 101 (06) : 1773 - U361
  • [7] OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS
    BEGG, CB
    MAZUMDAR, M
    [J]. BIOMETRICS, 1994, 50 (04) : 1088 - 1101
  • [8] Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the international lung cancer consortium
    Ben Khedher, Soumaya
    Neri, Monica
    Papadopoulos, Alexandra
    Christiani, David C.
    Diao, Nancy
    Harris, Curtis C.
    Olivo-Marston, Susan
    Schwartz, Ann G.
    Cote, Michele
    Koushik, Anita
    Siemiatycki, Jack
    Landi, Maria Teresa
    Hung, Rayjean J.
    McLaughlin, John
    Duell, Eric J.
    Andrew, Angeline S.
    Orlow, Irene
    Park, Bernard J.
    Brenner, Hermann
    Saum, Kai-Uwe
    Pesatori, Angela C.
    Stuker, Isabelle
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (02) : 309 - 323
  • [9] Estrogen replacement therapy and risk of lung cancer
    Blackman, JA
    Coogan, PF
    Rosenberg, L
    Strom, BL
    Zauber, AG
    Palmer, JR
    Langenberg, P
    Shapiro, S
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (07) : 561 - 567
  • [10] Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
    Bray, Freddie
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Siegel, Rebecca L.
    Torre, Lindsey A.
    Jemal, Ahmedin
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (06) : 394 - 424